Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1 Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1 Bth allele into the cochlea of neonatal Tmc1 Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1 Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, lipid-mediated nanoparticle (LNP) delivery has been used to transport CRISPR-Cas components in the form of either mRNA/sgRNA or preassembled RNPs into tissues 71-74 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [74]
In the citing paper
“Additionally, lower auditory response thresholds and improved acoustic responses were observed in injected mice.[226]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“The intraaural injection of Cas9 RNPs/lipofectamine 2000 complexes into the scala media of neonatal Tmc1Bth/+ mice significantly increased the survival of hair cells.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“All these results demonstrated that this system substantially reduced progressive hearing loss in Beethoven mouse model (Fig. 3B) [113].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 4×
“We identified three candidate sgRNAs (Tmc1-mut1, Tmc1-mut2, and Tmc1-mut3) that place the Bth mutation at position 11, 12, or 15, respectively, of the spacer, counting the PAM as positions 21-23 (Fig.”
InfluentialImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“A fourth sgRNA, Tmc1-mut4, is a truncated version of Tmc1-mut3 designed to increase genome editing DNA specificity 22 .”
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Newborn Hearing Screening — A Silent Revolution
Morton, C. C., & Nance, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050700 · Cited by 1,686
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Self-citationZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citationCRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Self-citationLong, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876
Self-citationEfficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520244113 · Cited by 624
Self-citation
Cited by
Items 401–500 of 566
Characterization of NiCas12b for In Vivo Genome Editing
Zhang, Y., Wei, J., Wang, H., & Wang, Y. (2024) · Advanced Science · doi:10.1002/advs.202400469 · Cited by 5
Self-citationFrom genome scissors to molecular scalpel: evolution of CRISPR systems
Guzmán-Zapata, D., Vargas-Morales, B. V., & Loyola-Vargas, V. M. (2021) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2021.1962071 · Cited by 5
The Synergy between CRISPR and Chemical Engineering
Lau, C., & Tin, C. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190701100556 · Cited by 5
Sun, H., Teng, Q., Liu, W., Guo, R., Li, M.-H., Xiong, W., Huang, Q., Yu, Q., Luo, N., Li, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67112-w · Cited by 5
Self-citationHearing loss: a global view for gene therapy approaches and challenges
Elbagoury, N. M. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06426-9 · Cited by 5
Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse model
Zhang, Z., Wang, M., Tan, F., Zhang, L., Wang, X., Chen, X., Han, J., Li, N., Sun, Q., Lu, Y., et al. (2026) · Med · doi:10.1016/j.medj.2026.101001 · Cited by 5
Progression of KCNQ4 related genetic hearing loss: a narrative review
Zhang, X., Wang, H., & Wang, Q. (2021) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000112 · Cited by 5
Self-citationGene therapy for deafness: we can do more
Chen, Y., Zhong, J., & Shu, Y. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00809-8 · Cited by 5
Self-citationLuo, Y., Wu, K., Zhang, X., Wang, H., & Wang, Q. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03617-9 · Cited by 5
Self-citationSilva, S. A., & Maass, J. C. (2018) · Hearing Research · doi:10.1016/j.heares.2018.12.002 · Cited by 5
[A review of diagnosis and treatment of syndromic hearing loss].
Liu, M., & Zhang, T. (2021) · PubMed Central · doi:10.13201/j.issn.2096-7993.2021.03.022 · Cited by 5
Genetically modified pigs: Emerging animal models for hereditary hearing loss
Wang, X., 中国科学院动物研究所干细胞与生殖生物学国家重点实验室, 北. 1., Liu, T.-X., Zhang, Y., Xu, L.-W., Yuan, S., Cui, A.-L., Guo, W., Wang, Y., Yang, S., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.231 · Cited by 5
Self-citationBEstimate: a computational tool for the design and interpretation of CRISPR base editing experiments
Dinçer, C., Fussing, B., Garnett, M. J., & Coelho, M. A. (2026) · Genome biology · doi:10.1186/s13059-026-04077-z · Cited by 4
Gene editing based hearing impairment research and therapeutics
Kang, W., Sun, Z., Zhao, X., Wang, X., Tao, Y., & Wu, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134326 · Cited by 4
Self-citationXiao, X., Yang, S., Jiang, G., & He, S. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2457781 · Cited by 4
Self-citationThe Auditory System Function - An Integrative Perspective
Grothe, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-805408-6.00009-9 · Cited by 4
Rescued from the fate of neurological disorder
Li, Y., Glass, Z., & Xu, Q. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0267-1 · Cited by 4
Self-citationUsher syndrome: Genetic diagnosis and current therapeutic approaches
Cuzzuol, B. R., Apolonio, J. S., Júnior, R. T. D. S., de Carvalho, L. S., Santos, L. K. D. S., Malheiro, L. H., Luz, M. S., Calmon, M. S., Crivellaro, H. D. L., Lemos, F. F. B., et al. (2024) · World Journal of Otorhinolaryngology · doi:10.5319/wjo.v11.i1.1 · Cited by 4
Advances in Inner Ear Therapeutics for Hearing Loss in Children
Aaron, K. A., Kim, G. S., & Cheng, A. G.-L. (2020) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-020-00300-y · Cited by 4
An ode to gene edits that prevent deafness
Urnov, F. D. (2017) · Nature · doi:10.1038/d41586-017-08645-z · Cited by 4
[Research progress in gene therapy for Wilson's disease].
Tang, S., Bai, L., & Zheng, S. (2021) · Zhonghua ganzangbing zazhi · doi:10.3760/cma.j.cn501113-20201104-00598 · Cited by 4
Zhang, X., Wang, H., Li, J., Li, D., Wu, K., Wu, X., & Wang, Q. (2023) · PubMed Central · doi:10.13201/j.issn.2096-7993.2023.01.005 · Cited by 4
Self-citationTumor-on-a-chip devices for cancer immunotherapy
Mu, X., & Zhang, Y. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00006-1 · Cited by 3
Gildon, W. F. (2021) · Digital Commons (Liberty University) · Cited by 3
Saberi, F., Yousefi-Najafabadi, Z., Shams, F., Dehghan, Z., Ahmadi, S., Pilehchi, T., Noori, E., Esmaeelzadeh, Z., Bazgiri, M., Mohammadi, R., et al. (2025) · Current Gene Therapy · doi:10.2174/0115665232345516241119070150 · Cited by 3
Sistema CRISPR/Cas9 e perspectivas de aplicações na cadeia produtiva animal
da Costa, C. P., Assumpção, M. E. O. D., & Goissis, M. D. (2021) · Revista Brasileira de Reprodução Animal · doi:10.21451/1809-3000.rbra2021.003 · Cited by 3
Non-viral delivery of genome-editing tools for treatment of genetic disorders
Yang, J., Chen, Y., Chen, X., & Ping, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.014 · Cited by 3
Pasch, T., Bäumer, N., Bäumer, S., Buchholz, F., & Mootz, H. D. (2024) · Journal of Peptide Science · doi:10.1002/psc.3592 · Cited by 3
Madsen, A., Selfjord, N., Martínez-Lage, M., Loyd, A.-L., Kurgan, G., Stahlberg, M., Lindgren, J., Touza, J. L., Wigge, L., Firth, M. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77144-5 · Cited by 3
Zhao, X., Xu, H., Lian, C., Hu, S., Zhao, Y., Wang, J., Zhai, R., Yang, M., Zhang, Y., Lu, W., et al. (2025) · Gene Therapy · doi:10.1038/s41434-025-00558-1 · Cited by 3
Perspektiven der Genomeditierung in der Hals-Nasen-Ohren-Heilkunde
Oppel, F., Schürmann, M., Shao, S., Kaltschmidt, B., Kaltschmidt, C., & Sudhoff, H. H. (2019) · HNO · doi:10.1007/s00106-019-0613-y · Cited by 3
Wang, F., Li, Y., Xu, J., Tang, W., Xu, X., Lou, X., Jing, D., Fan, G., Qin, Y., Chen, J., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c21452 · Cited by 3
Self-citationEmerging Therapeutic Strategies for Hearing Loss
Han, S., Shen, T., He, W., Wei, H., Zhao, X., Yang, W., Bu, C., Tang, X., Zhao, Y., & Fan, J. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500127 · Cited by 3
Toutou, M. M. M. (2024) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2024.341426 · Cited by 3
Direct preparation of Cas9 ribonucleoprotein from E. coli for PCR-free seamless DNA assemblyPreprint
Li, W., Li, S., Qiao, J., wang, F., Liu, Y., He, R., Liu, Y., & Ma, L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/328468 · Cited by 3
Zhang, T., Zhai, R., Liu, M., Xu, H., Wang, L., Tang, W., Chen, B., & Zhao, X. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101539 · Cited by 3
A CRISPR Way to Restore Hearing
Chien, W. W. (2018) · New England Journal of Medicine · doi:10.1056/nejmcibr1716789 · Cited by 3
Natural History of KCNQ4 p.G285S Related Hearing Loss, Construction of iPSC and Mouse Model
Zhang, X., Shi, T., Li, J., Wu, X., Wu, K., Li, D., Wang, D., Guan, J., & Wang, H. (2023) · The Laryngoscope · doi:10.1002/lary.31179 · Cited by 3
Self-citationOptogenetic stimulation of the cochlea
de la Morena, D. L. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7546 · Cited by 2
Research Progress on MET, Tip Link, and Stereocilia Complex with Special Reference to Zebrafish
Wang, X., Shen, Y., & Liu, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178480 · Cited by 2
Self-citationEchoes in the night: How sleep quality influences auditory health
Zhang, P., An, X., Yang, R., Qi, M., Gao, Z., Zhang, X., Wu, Z., Zheng, Z., Dong, X., Wang, W., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.039 · Cited by 2
CRISPR and genome editing: precision tools for personalized therapies
Ranga, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00047-9 · Cited by 2
Therapeutic approaches and development of genomic diagnostic tools for Usher syndrome
García, C. F. (2020) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/137034 · Cited by 2
A review of application of base editing for the treatment of inner ear disorders
Zhao, X., Sun, Z., Kang, W., Tao, Y., & Wu, H. (2020) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000040 · Cited by 2
Self-citationMilenkovic, A., & Weber, B. H. F. (2026) · Genome Medicine · doi:10.1186/s13073-026-01649-3 · Cited by 2
OBSOLETE: The Auditory System Function - An Integrative Perspective
Grothe, B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00009-2 · Cited by 2
Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing
Kong, Y., Zhang, Y. L., Xie, E., Li, X., Peng, Z., Zhang, J., Zhao, Y., & Yuan, H. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00433-5 · Cited by 2
Nonviral gene editing in cancer immunotherapy
Li, Y., & Xu, Q. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00010-5 · Cited by 2
Self-citationCRISPR Base Editing Correction of TGFBI Mutations in Autosomal Dominant Corneal Dystrophies
Chen, J., Davison, C. W., Ellis, J., Blevins, B., Presley, W., Myers, M., Kong, D., Hou, Z., Mian, S. I., Prasov, L., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.60 · Cited by 2
Qiao, J., Sun, W., Yin, W., Ma, L., & Liu, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.17.484717 · Cited by 2
Hereditary kidney disease with auditory abnormalities: analysis of mutations and clinical phenotypes
Bi, J., Guo, W., Ji, P., & Xie, Y. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02178-5 · Cited by 2
Chneiweiss, H. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.04.006 · Cited by 2
Tissue engineering and regenerative medicine in otorhinolaryngology
Dinaki, K., Grigoriadis, N., Vizirianakis, I. S., Constantinidis, J., Triaridis, S., & Karkos, P. D. (2024) · Journal of Clinical and Translational Research · doi:10.36922/jctr.22.00151 · Cited by 2
Hana, M., & Abdeen, E. E.-S. (2024) · Alexandria Journal of Veterinary Sciences · doi:10.5455/ajvs.182437 · Cited by 2
Wallingford, N. M., Frey, J., & Evering, W. (2018) · Journal of Histotechnology · doi:10.1080/01478885.2018.1470133 · Cited by 2
Ion channel-related hereditary hearing loss: a narrative review
Zheng, H., Cui, W., & Yan, Z. (2021) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000108 · Cited by 2
Molecular Determinants of TMC Protein Biogenesis and Trafficking
Shao, D., Tan, J., Fan, X., Shu, Y., Qu, Q., & Tang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136356 · Cited by 1
Self-citationDirect purification of CRISPR/Cas ribonucleoprotein from E. coli in a single stepPreprint
Lin, S., Qiao, J., Ma, L., & Liu, Y. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/377366 · Cited by 1
Genome Editing with CRISPR‐Cas Systems
Lotfy, P., & Hsu, P. D. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch11 · Cited by 1
Integrated Approach to Precision Oncology
Mohtar, M. A., Syafruddin, S. E., Abdullah‐Zawawi, M., Jalal, M. I. A., Low, T. Y., & Tan, S. C. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_450 · Cited by 1
CRISPR Therapies for Alzheimer’s Disease
Sun, J., & Roy, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_12 · Cited by 1
Hearing impairment: new frontiers of regenerative medicine
Franzè, A., Miceli, M., VECCHIO, V. D., Auletta, G., Laria, C., Malesci, R., & Marciano, E. (2021) · Otorhinolaryngology · doi:10.23736/s2724-6302.21.02381-1 · Cited by 1
Emerging Therapies and Approaches to Treat and Prevent Hearing Loss
Koleilat, A., Driscoll, C. L. W., Schimmenti, L. A., & Poling, G. L. (2020) · Perspectives of the ASHA Special Interest Groups · doi:10.1044/2020_persp-20-00072 · Cited by 1
CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer
Talukder, P., Chanda, S., Chaudhuri, B., Choudhury, S. R., Saha, D., Dash, S., Banerjee, A., & Chatterjee, B. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04708-2 · Cited by 1
Gene Editing Technologies for Hereditary Hearing Loss: Prospects and Challenges
Wang, M., Wang, B., Yang, M., Tan, F., Qi, J., & Chai, R. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01651-0 · Cited by 1
A “CRISPY” tale on microalgal genome editing: featuring Nannochloropsis oceanica IMET1
Naduthodi, M. I. S. (2021) · doi:10.18174/555308 · Cited by 1
Tamura, R., Yo, M., & Toda, M. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-04995-1 · Cited by 1
Precision Medicine Shows Promise to Advance the Care of Individuals with Hearing Loss
Pei, M., Colbert, B., Smea, M., Blanton, S. H., & Liu, X. Z. (2022) · Medical Research Archives · doi:10.18103/mra.v10i11.3298 · Cited by 1
Self-assembled structures as emerging cellular scaffolds
Gaur, D., Dubey, N. C., & Tripathi, B. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99472-9.00023-7 · Cited by 1
Diagnosis and Intervention of Genetic Hearing Loss
Na, G., & Jung, J. (2021) · Journal of Clinical Otolaryngology Head and Neck Surgery · doi:10.35420/jcohns.2021.32.1.5 · Cited by 1
Cochlear Implants: Future Directions
Kara, E., Çögen, T., & Rubinstein, J. T. (2024) · Comprehensive ENT · doi:10.1007/978-3-031-77370-9_28 · Cited by 1
Myosin XVA: dancing at the tips of the stereocilia
Du, H., Li, N., & Xu, Z. (2020) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000060 · Cited by 1
53BP1 nuclear body-marked replication stress in a human mammary cell model of BRCA2 deficiencyPreprint
Feng, W., & Jasin, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462119 · Cited by 1
Cas9-induced on-target genomic damage
Kosicki, M. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.37162 · Cited by 1
Hovev, Z., Moverman, D. J., Quesnel, A. M., & Handzel, O. (2025) · Audiology and Neurotology · doi:10.1159/000548540 · Cited by 1
Precision medicine: recent advances, current challenges and future perspectives
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5042-7 · Cited by 1
Iranfar, S. (2024) · theses.fr (ABES) · doi:10.70675/40468943z8d78z4ac7za30ez7514241e052e · Cited by 1
Interacting MeZFP29 and MebZIPW regulates MeNRT2.2 from cassava responding to nitrate signaling
Li, W., Yu, X., Zhao, P., Li, S., Zou, L., Zhang, X., Li, J., & Ruan, M. (2025) · Plant Cell Reports · doi:10.1007/s00299-025-03455-4 · Cited by 1
Future View of Regenerative Research for Vestibular Disorders
Taura, A., Ohnishi, H., Nishimura, K., Hideaki, O., Nakagawa, T., Yamamoto, N., Okano, T., Ohmori, K., & Ito, J. (2019) · Equilibrium Research · doi:10.3757/jser.78.219 · Cited by 1
Challenges and future prospects of chitosan nanostructures in environmental remediation
Malik, S., Khan, A., Bououdina, M., Ali, N., Khan, S. H., Rahman, S., Ali, M. F., Khan, M. H., & Aldaghri, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21891-0.00022-6 · Cited by 1
Moradi, A., Doulabi, S.-R. S.-M., Vaziri, A., Helbig, S., & Baghi, M. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-025-09957-x · Cited by 1
Gene therapy for inner ear disorders: a step into the future
Markova, T. G., & Bakhshinyan, V. V. (2025) · Russian Bulletin of Otorhinolaryngology · doi:10.17116/otorino20259004185 · Cited by 1
Xia, S., Dai, W., & Wu, J. (2026) · Translational Cancer Research · doi:10.21037/tcr-2025-aw-2286 · Cited by 1
Synthetic Biology Approaches to Study and Control the Transcriptome
Rauch, S. (2020) · Knowledge@UChicago (University of Chicago) · doi:10.6082/3q36t-exv18 · Cited by 1
誠, 細., & 正人, 藤. (2019) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.122.1508 · Cited by 1
Liu, Y., & Zhang, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-6487 · Cited by 1
Liu, Y., Hu, B., Zhang, J., Wu, X., Lu, Q., Jia, Y., & Kou, Z. (2026) · Gene Therapy · doi:10.1038/s41434-026-00641-1
Development of targeted methylome modifications in mammal cells
Lleida, A. A. (2018) · theses.fr (ABES) · doi:10.70675/6e05a7d8z70caz4650zb774z4d6156ab4205
Thérapie génique translationnelle des surdités et troubles vestibulaires d'origine génétique
Lahlou, G. (2020) · theses.fr (ABES) · doi:10.70675/d992d926z590ez4d57zbb4fza9922aca932f
Application of CRISPR/Cas system in iPSC-based disease model of hereditary deafness
Giri, S., & Malgrange, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00009-8
Innovative approaches to genome editing in the treatment of neurodegenerative diseases
Tereshchenko, C. Y., Potupchik, T. V., Evert, L. S., Kovalchuk, V. A., Filippova, M. A., & Magalova, A. R. (2024) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2024-06-04
Nano Delivery Systems for In Vivo CRISPR/Cas-Based Gene Therapy: From Vectors to Clinical Outcomes
Chen, R., Zhou, H., Wu, Q., & Gong, C. (2026) · ACS Nano · doi:10.1021/acsnano.6c12154
Development of CRISPR/Cas-mediated gene editing in the retina
Li, F. (2020) · UTAS Research Repository · doi:10.25959/23249972
Basic and clinical research progress of AAV-based gene therapy <?A3B2 pi6?>for hereditary deafness
Zhou, Y., Yang, X., Lu, Y., Wang, X., Chen, X., Fan, J., ZHANG, X., Wu, X., Zhang, L., Tan, F., et al. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0031
Synaptopathies auditives et vestibulaires : de la physiologie moléculaire à la thérapie génique
Calvet, C. (2020) · theses.fr (ABES) · doi:10.70675/8920e327zd8ffz457ez9711zcfc53af428dc
CRISPRing through time: How cutting-edge technology is revolutionizing life sciences and medicine
Banik, I., & Coppé, J. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103003
da Costa, C. P. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2020.tde-23022021-144131
Extension and Improvement of CRISPR-Based Technology
Zhang, Z., Wang, P., & Liu, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-8504-0_3
Cho, S. H., Yun, Y., Lee, D. H., Cha, J. H., Lee, S. M., Lee, J., Suh, M. H., Lee, J. H., Oh, S.-H., Park, M. K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24779366
Metadata
- Authors
- Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., Li, Y., Wang, H., Yang, S., Xu, Q., Polley, D. B., Liberman, M. C., Kong, W.-J., Holt, J. R., Chen, Z.-Y., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Massachusetts Eye and Ear Infirmary (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Tufts University (US)
- Corresponding author
- Chen, Zheng-Yi
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7687
- Pages
- 217-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5784267
- OpenAlex
- W2778806019
- Cited by
- 536
- References
- 28
- Citations by year
- 2026: 25 · 2025: 43 · 2024: 58 · 2023: 62 · 2022: 64 · 2021: 60 · 2020: 101 · 2019: 67 · 2018: 54 · 2017: 1
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (2r01dc013521-11a1)
- National Institute on Deafness and Other Communication Disorders (R01-DC013521, R01DC009836, P30DC005209, R01DC006908, F32DC000138, R01DC000188)
- National Institute of General Medical Sciences (R35GM118062)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- autosomal dominant hearing loss, CRISPR/Cas9 genome editing, in vivo gene delivery, dominant negative mutation, auditory brainstem response, acoustic startle response
- MeSH terms
- Gene Editing, Acoustic Stimulation, Alleles, Animals, Animals, Newborn, Auditory Threshold, Base Sequence, Cell Survival, Cochlea, Disease Models, Animal, Female, Fibroblasts, Genes, Dominant, Hair Cells, Auditory, Humans, Liposomes, Male, Membrane Proteins, Reflex, Startle, Genetic Therapy, Evoked Potentials, Auditory, Brain Stem, Hearing Loss, Mice, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.